Added to YB: 2025-03-20
Pitch date: 2025-01-31
ARAY [bullish]
Accuray Incorporated
-52.7%
current return
Author Info
No bio for this author
Company Info
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.
Market Cap
$117.9M
Pitch Price
$2.22
Price Target
6.00 (+466%)
Dividend
N/A
EV/EBITDA
10.41
P/E
-5.79
EV/Sales
0.52
Sector
Health Care Equipment and Supplies
Category
value
Accuray Incorporated - $ARAY
ARAY: Underfollowed microcap med tech co. at 0.5x FY25E rev. China Type B approval Jun'24 unlocks $600M annual opp. 50% rev from annuity-like service contracts. FY24 guidance cut on US hospital budget delays & China approval timing. Expect rev/margin growth in FY25+. Takeover potential at 1-1.45x FY25 rev.
Read full article (8 min)